Skip to main content
. 2021 Apr 22;22(9):4358. doi: 10.3390/ijms22094358

Figure 1.

Figure 1

Components of the fibrinolytic system. The drug/inhibitors targeting the key members of the fibrinolytic system (uPA, uPAR, and PAI-1) that are deregulated in cancer are listed inside the colored boxes.